vs
SUTRO BIOPHARMA, INC.（STRO）与USCB FINANCIAL HOLDINGS, INC.（USCB）财务数据对比。点击上方公司名可切换其他公司
USCB FINANCIAL HOLDINGS, INC.的季度营收约是SUTRO BIOPHARMA, INC.的1.9倍（$22.2M vs $11.6M），USCB FINANCIAL HOLDINGS, INC.同比增速更快（14.7% vs -21.4%），过去两年USCB FINANCIAL HOLDINGS, INC.的营收复合增速更高（12.3% vs -5.4%）
Sutro Biopharma是一家上市生物科技公司，总部位于加州南旧金山，专注于临床阶段药物的研发、开发与生产。公司依托自主专有的无细胞蛋白质合成平台，结合蛋白质工程与理性设计技术开发肿瘤治疗药物。公司2003年成立时名为Fundamental Applied Biology，2009年改用现名。
USCB金融控股公司是一家总部位于美国的银行控股企业，提供全面的零售与商业银行业务，包括存款产品、个人及企业贷款、财富管理及数字银行服务，主要服务个人消费者、中小微企业及当地企业客户，主打个性化服务与社区导向的金融支持。
STRO vs USCB — 直观对比
营收规模更大
USCB
是对方的1.9倍
$11.6M
营收增速更快
USCB
高出36.1%
-21.4%
两年增速更快
USCB
近两年复合增速
-5.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $11.6M | $22.2M |
| 净利润 | — | $1.4M |
| 毛利率 | — | — |
| 营业利润率 | — | 14.7% |
| 净利率 | — | 6.1% |
| 营收同比 | -21.4% | 14.7% |
| 净利润同比 | 35.4% | -80.3% |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收STROUSCB
| Q4 25 | $11.6M | $22.2M | ||
| Q3 25 | $9.7M | $25.0M | ||
| Q2 25 | $63.7M | $24.4M | ||
| Q1 25 | $17.4M | $22.8M | ||
| Q4 24 | $14.8M | $23.0M | ||
| Q3 24 | $8.5M | $21.5M | ||
| Q2 24 | $25.7M | $20.5M | ||
| Q1 24 | $13.0M | $17.6M |
净利润STROUSCB
| Q4 25 | — | $1.4M | ||
| Q3 25 | $-56.9M | $8.9M | ||
| Q2 25 | $-11.5M | $8.1M | ||
| Q1 25 | $-76.0M | $7.7M | ||
| Q4 24 | $-72.4M | $6.9M | ||
| Q3 24 | $-48.8M | $6.9M | ||
| Q2 24 | $-48.0M | $6.2M | ||
| Q1 24 | $-58.2M | $4.6M |
营业利润率STROUSCB
| Q4 25 | — | 14.7% | ||
| Q3 25 | -499.9% | 47.3% | ||
| Q2 25 | -5.2% | 44.0% | ||
| Q1 25 | -393.8% | 44.2% | ||
| Q4 24 | -440.7% | 39.6% | ||
| Q3 24 | -797.2% | 42.5% | ||
| Q2 24 | -189.4% | 39.8% | ||
| Q1 24 | -435.0% | 34.3% |
净利率STROUSCB
| Q4 25 | — | 6.1% | ||
| Q3 25 | -586.6% | 35.8% | ||
| Q2 25 | -18.0% | 33.4% | ||
| Q1 25 | -436.6% | 33.5% | ||
| Q4 24 | -489.2% | 30.0% | ||
| Q3 24 | -572.6% | 32.3% | ||
| Q2 24 | -186.8% | 30.3% | ||
| Q1 24 | -447.5% | 26.2% |
每股收益（稀释后）STROUSCB
| Q4 25 | — | — | ||
| Q3 25 | $-0.67 | $0.45 | ||
| Q2 25 | $-0.14 | — | ||
| Q1 25 | $-0.91 | — | ||
| Q4 24 | $-27.63 | — | ||
| Q3 24 | $-0.59 | $0.35 | ||
| Q2 24 | $-0.59 | — | ||
| Q1 24 | $-0.59 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $141.4M | $38.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-132.5M | $217.2M |
| 总资产 | $173.8M | $2.8B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资STROUSCB
| Q4 25 | $141.4M | $38.5M | ||
| Q3 25 | $167.6M | $56.8M | ||
| Q2 25 | $205.1M | $54.8M | ||
| Q1 25 | $249.0M | $98.0M | ||
| Q4 24 | $316.9M | $77.0M | ||
| Q3 24 | $388.3M | $38.5M | ||
| Q2 24 | $375.6M | $77.3M | ||
| Q1 24 | $267.6M | $126.5M |
股东权益STROUSCB
| Q4 25 | $-132.5M | $217.2M | ||
| Q3 25 | $-87.3M | $209.1M | ||
| Q2 25 | $-32.1M | $231.6M | ||
| Q1 25 | $-25.8M | $225.1M | ||
| Q4 24 | $44.6M | $215.4M | ||
| Q3 24 | $111.2M | $213.9M | ||
| Q2 24 | $152.2M | $201.0M | ||
| Q1 24 | $98.0M | $195.0M |
总资产STROUSCB
| Q4 25 | $173.8M | $2.8B | ||
| Q3 25 | $209.7M | $2.8B | ||
| Q2 25 | $262.4M | $2.7B | ||
| Q1 25 | $321.4M | $2.7B | ||
| Q4 24 | $387.2M | $2.6B | ||
| Q3 24 | $451.8M | $2.5B | ||
| Q2 24 | $489.0M | $2.5B | ||
| Q1 24 | $403.4M | $2.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-177.2M | $42.8M |
| 自由现金流经营现金流 - 资本支出 | — | $42.5M |
| 自由现金流率自由现金流/营收 | — | 191.4% |
| 资本支出强度资本支出/营收 | — | 1.4% |
| 现金转化率经营现金流/净利润 | — | 31.40× |
| 过去12个月自由现金流最近4个季度 | — | $95.1M |
8季度趋势，按日历期对齐
经营现金流STROUSCB
| Q4 25 | $-177.2M | $42.8M | ||
| Q3 25 | $-38.2M | $20.1M | ||
| Q2 25 | $-44.7M | $18.0M | ||
| Q1 25 | $-67.9M | $14.6M | ||
| Q4 24 | $-71.7M | $34.8M | ||
| Q3 24 | $-64.5M | $11.3M | ||
| Q2 24 | $9.5M | $18.3M | ||
| Q1 24 | $-64.7M | $8.1M |
自由现金流STROUSCB
| Q4 25 | — | $42.5M | ||
| Q3 25 | — | $20.0M | ||
| Q2 25 | — | $18.0M | ||
| Q1 25 | — | $14.6M | ||
| Q4 24 | — | $34.5M | ||
| Q3 24 | — | $11.2M | ||
| Q2 24 | — | $18.2M | ||
| Q1 24 | — | $8.0M |
自由现金流率STROUSCB
| Q4 25 | — | 191.4% | ||
| Q3 25 | — | 80.3% | ||
| Q2 25 | — | 73.7% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 150.2% | ||
| Q3 24 | — | 52.2% | ||
| Q2 24 | — | 88.8% | ||
| Q1 24 | — | 45.4% |
资本支出强度STROUSCB
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | 0.5% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 1.4% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | — | 0.5% |
现金转化率STROUSCB
| Q4 25 | — | 31.40× | ||
| Q3 25 | — | 2.25× | ||
| Q2 25 | — | 2.22× | ||
| Q1 25 | — | 1.91× | ||
| Q4 24 | — | 5.05× | ||
| Q3 24 | — | 1.63× | ||
| Q2 24 | — | 2.95× | ||
| Q1 24 | — | 1.75× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
